Bolt Biotherapeutics (BOLT) Misses Q1 EPS by 431c
Tweet
Share
E-mailGet Alerts BOLT Hot Sheet
Join SI Premium – FREE
Bolt Biotherapeutics (NASDAQ: BOLT) reported Q1 EPS of ($4.31). Revenue for the quarter came in at $30 thousand.
For earnings history and earnings-related data on Bolt Biotherapeutics (BOLT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
